|?|| (C;C) (C;T) (T;T) ||28|
] XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer
[PMID 20233728] Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
[PMID 22981091] Association between polymorphisms of DNA repair gene ERCC5 and oral squamous cell carcinoma.
[PMID 22982416] Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese.
[PMID 23211354] Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
[PMID 25644244] Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China
[PMID 27228234] XPG Gene Polymorphisms and the Risk of Gastric Cardiac Adenocarcinoma.
[PMID 27235448] Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells.
[PMID 28115302] Interactions among polymorphisms of NER genes prompt the risk of transplantation rejection.